US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adial Pharmaceuticals

0.6700

-0.1100-14.10%

Post-market: 0.67830.0083+1.24%19:58 EDT

Volume:23.70M

Turnover:23.59M

Market Cap:4.40M

PE:-0.25

High:1.21

Open:0.9080

Low:0.6308

Close:0.7800

Loading ...

Overview Company News Filings

Press Release: Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

Adial Pharmaceuticals Expands Intellectual Property Portfolio With New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders

THOMSON REUTERS

Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders

EXCLUSIVE: Adial Pharmaceuticals Expands Patent Portfolio With New US Patent For Lead Drug For Alcohol And Opioid Use Disorders

Adial Pharmaceuticals Appoints Tony Goodman as COO

Adial Pharmaceuticals FY 2024 GAAP EPS $(2.72) Beats $(2.97) Estimate

Adial Pharmaceuticals expects cash to fund operations into 2H of 2025

Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update

BUZZ-Adial Pharma jumps on regulatory pathway for alcohol-use disorder drug

Adial Pharmaceuticals Advances AD04 with FDA Approval

BRIEF-Adial Pharma Receives Positive Response From FDA Meeting Regarding Vitro Bridging Strategy For AD04

Adial says FDA feedback confirms proposed strategy to AD04 Phase 3 formulation

Adial Pharmaceuticals Receives Positive Response From FDA Meeting Regarding Proposed in Vitro Bridging Strategy for Ad04

THOMSON REUTERS

Adial Pharmaceuticals- Moves Forward With Manufacturing Clinical Supplies for Phase 3 Program in 2025

THOMSON REUTERS

Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

EXCLUSIVE: After FDA Response, Adial Starts Manufacturing Clinical Supplies For Upcoming Phase 3 Program Of Lead Candidate For Alcohol Use Disorder

BRIEF-Adial Pharmaceuticals Granted New U.S. Patent On Method To Identify Genetic Markers In Alcohol or Opioid-Related Disorders

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of Its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

THOMSON REUTERS

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

Adial Pharmaceuticals awarded new U.S. patent on genotype-specific treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ADIL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADIL\",,,,,undefined,":{"symbol":"ADIL","market":"US","secType":"STK","nameCN":"Adial Pharmaceuticals","latestPrice":0.67,"timestamp":1746216000000,"preClose":0.78,"halted":0,"volume":23700212,"hourTrading":{"tag":"盘后","latestPrice":0.6783,"preClose":0.67,"latestTime":"19:58 EDT","volume":126100,"amount":83799.1328,"timestamp":1746230300503},"delay":0,"floatShares":6146400,"shares":6574588,"eps":-2.720289,"marketStatus":"Market Closed","change":-0.11,"latestTime":"05-02 16:00:00 EDT","open":0.908,"high":1.21,"low":0.6308,"amount":23594452.173971202,"amplitude":0.742564,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.720289,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1532664000000,"exchange":"NASDAQ","adjPreClose":0.78,"preHourTrading":{"tag":"盘前","latestPrice":0.8594,"preClose":0.78,"latestTime":"09:29 EDT","volume":1224448,"amount":1117175.5800576,"timestamp":1746192596075},"postHourTrading":{"tag":"盘后","latestPrice":0.6783,"preClose":0.67,"latestTime":"19:58 EDT","volume":126100,"amount":83799.1328,"timestamp":1746230300503},"volumeRatio":16.570127459406585,"impliedVol":3.592,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADIL\",,,,,undefined,":{"symbol":"ADIL","floatShares":6146400,"roa":"-105.88%","roe":"-323.80%","lyrEps":-2.720289,"volumeRatio":16.570127459406585,"shares":6574588,"dividePrice":0,"high":1.21,"amplitude":0.742564,"preClose":0.78,"low":0.6308,"week52Low":0.5759,"pbRate":"1.08","week52High":3,"institutionHeld":0,"latestPrice":0.67,"eps":-2.720289,"divideRate":0,"volume":23700212,"delay":0,"ttmEps":-2.720289,"open":0.908,"prevYearClose":1.01,"prevWeekClose":0.685,"prevMonthClose":0.69,"prevQuarterClose":0.6342,"fiveDayClose":0.685,"twentyDayClose":0.6748,"sixtyDayClose":0.8183},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADIL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532079826","title":"Press Release: Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2532079826","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532079826?lang=en_us&edition=fundamental","pubTime":"2025-05-02 23:48","pubTimestamp":1746200880,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., May 02, 2025  --  Adial Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced its entry into a warrant inducement agreement with an existing healthcare-focused institutional investor of the Company for the immediate exercise of existing Series B Warrants  to purchase up to 1,418,440 shares of the Company's common stock, par value $0.001 per share , and Series C Warrants  to purchase up to 2,300,000 shares of Common Stock at a reduced exercise price of $0.74 for gross cash proceeds of approximately $2.75 million, before deducting financial advisor fees and other transaction expenses. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes.A.G.P./Alliance Global Partners is acting as the financial advisor in this warrant inducement transaction.This press release does not constitut","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","ADIL","BK4099","BK4585","BK4555","BK4007","NQmain","BK4604","BK4588","03160"],"gpt_icon":0},{"id":"2532074572","title":"Adial Pharmaceuticals Expands Intellectual Property Portfolio With New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2532074572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532074572?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:30","pubTimestamp":1746102600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nTUA68M4HK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2532074718","title":"Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2532074718","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532074718?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:30","pubTimestamp":1746102600,"startTime":"0","endTime":"0","summary":"New patent covers a treatment method for a broad spectrum of alcohol-related disorders, including additional conditions associated with alcohol use. GLEN ALLEN, Va., May 01, 2025  -- Adial Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced patent number 12,274,692 was issued on April 15, 2025 by the United States Patent and Trademark Office  covering a novel method of treating alcohol-related diseases and opioid-related disorders using AD04 in genetically identified patients.Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of therapies for the treatment and prevention of addiction and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder  in heavy drinking patients an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adial-pharmaceuticals-expands-intellectual-property-123000360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2532074710","title":"EXCLUSIVE: Adial Pharmaceuticals Expands Patent Portfolio With New US Patent For Lead Drug For Alcohol And Opioid Use Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2532074710","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532074710?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:02","pubTimestamp":1746100961,"startTime":"0","endTime":"0","summary":"The United States Patent and Trademark Office  issued patent number 12,274,692 to Adial Pharmaceuticals, Inc.’s  AD04 on Thursday.The patent covers a method of treating alcohol-related diseases and opioid-related disorders using AD04 in genetically identified patients.This newly issued patent strengthens Adial’s intellectual property portfolio by covering the administration of AD04, the company’s investigational drug.Also Read: EXCLUSIVE: After FDA Response, Adial Starts Manufacturing Clinical Supplies For Upcoming Phase 3 Program Of Lead Candidate For Alcohol Use Disorder. The patent claims a method of treating addiction by administering a therapeutically effective amount of AD04 to patients with serotonin-related gene variations.The granted claims include specific genetic profiles associated with treatment efficacy and the corresponding dosing regimens.Specifically for AUD, the patent claims cover a method of treatment for a broad definition of alcohol-related disorders, includingdis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-adial-pharmaceuticals-expands-patent-120241165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4218","ADIL","BK4007","PK","BK4181"],"gpt_icon":0},{"id":"2521520492","title":"Adial Pharmaceuticals Appoints Tony Goodman as COO","url":"https://stock-news.laohu8.com/highlight/detail?id=2521520492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521520492?lang=en_us&edition=fundamental","pubTime":"2025-03-22 04:55","pubTimestamp":1742590508,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) has issued an update. On March 20, 2025, Adial Pharmaceuticals entered into an employment agreement with Tony Goo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-appoints-tony-goodman-as-coo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-appoints-tony-goodman-as-coo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1992135399.USD","BK4198","BK4585","BK4007","GB00BDT5M118.USD","LU2272731782.SGD","LU2272731600.USD","LU1992135472.HKD","COO","ADIL","LU2211815571.USD"],"gpt_icon":0},{"id":"2516670588","title":"Adial Pharmaceuticals FY 2024 GAAP EPS $(2.72) Beats $(2.97) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670588","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516670588?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:50","pubTimestamp":1741099830,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(2.72) per share which beat the analyst consensus estimate of $(2.97) by 8.42 percent. This is a 24.44 percent increase over losses of $(3.60) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44110145/adial-pharmaceuticals-fy-2024-gaap-eps-2-72-beats-2-97-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adial Pharmaceuticals FY 2024 GAAP EPS $(2.72) Beats $(2.97) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL"],"gpt_icon":0},{"id":"2516715506","title":"Adial Pharmaceuticals expects cash to fund operations into 2H of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516715506","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516715506?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:36","pubTimestamp":1741095407,"startTime":"0","endTime":"0","summary":"Cash and cash equivalents were $3.8 million as of December 31, 2024, compared to $2.8 million as of December 31, 2023. The Company believes that it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-expects-cash-to-fund-operations-into-2h-of-2025-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-expects-cash-to-fund-operations-into-2h-of-2025-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2516679483","title":"Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2516679483","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516679483?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., March 04, 2025  -- Adial Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2024 fiscal year ended December 31, 2024.Successful completion of AD04-103 pharmacokinetics  study of AD04, corroborating bioavailability, dose proportionality, no food effect, and safety profile consistent with the use of Ondansetron.Advancement towards pivotal Phase 3 trial design supportive of ongoing partnership discussions.FDA confirmation of proposed 505 bridging strategy leveraging the results from AD04-103—a relative bioavailability food-effect study—along with in vitro dissolution data demonstrating equivalence between the reference product and the planned commercial formulation of AD04.“In addition to the key highlights mentioned, we strengthened our regulatory strategy by partnering with Boudi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adial-pharmaceuticals-reports-2024-fiscal-133000017.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4006","LU0971096721.USD","LU1363072403.SGD","IE00BZ1G4Q59.USD","CMC","IE00BHPRN162.USD","LU0149725797.USD","BK4218","ADIL","IE00BKVL7J92.USD","LU0267386448.USD","BK4007","BK4181","LU0170899867.USD","PK","LU0882574139.USD","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2514137310","title":"BUZZ-Adial Pharma jumps on regulatory pathway for alcohol-use disorder drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2514137310","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514137310?lang=en_us&edition=fundamental","pubTime":"2025-02-25 23:18","pubTimestamp":1740496721,"startTime":"0","endTime":"0","summary":"BUZZ-Adial Pharma jumps on regulatory pathway for alcohol-use disorder drug** Shares of drug developer Adial Pharmaceuticals ADIL.O rise as much as 68.8% to $1.30** ADIL says U.S. FDA agreed with co's plan to use a specific approach called \"in vitro bridging strategy\" to support the development of AD04, to treat alcohol-use disorder in heavy-drinking patients** This approach involves using existing data and lab tests to show that the new version of AD04 is equivalent to the previous version** Co is developing the drug for its upcoming late-stage trial, set to begin this year** Last year, AD04 showed safety and tolerability consistent with an existing treatment** ADIL fell 42.3% in 2024  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3N3PG1LN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2514090706","title":"Adial Pharmaceuticals Advances AD04 with FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090706","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514090706?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:44","pubTimestamp":1740494672,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) has issued an announcement. On February 25, 2025, Adial Pharmaceuticals announced a positive response from the FD...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-advances-ad04-with-fda-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-advances-ad04-with-fda-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2514609069","title":"BRIEF-Adial Pharma Receives Positive Response From FDA Meeting Regarding Vitro Bridging Strategy For AD04","url":"https://stock-news.laohu8.com/highlight/detail?id=2514609069","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514609069?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:43","pubTimestamp":1740494583,"startTime":"0","endTime":"0","summary":"BRIEF-Adial Pharma Receives Positive Response From FDA Meeting Regarding Vitro Bridging Strategy For AD04Feb 25 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:ADIAL PHARMACEUTICALS RECEIVES POSITIVE RES","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA8ZSHD9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2514929500","title":"Adial says FDA feedback confirms proposed strategy to AD04 Phase 3 formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2514929500","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514929500?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:05","pubTimestamp":1740492310,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals (ADIL) announced a “positive” response from the U.S. FDA regarding its proposed in vitro bridging strategy for AD04. The FDA’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adial-says-fda-feedback-confirms-proposed-strategy-to-ad04-phase-3-formulation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adial-says-fda-feedback-confirms-proposed-strategy-to-ad04-phase-3-formulation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2514850092","title":"Adial Pharmaceuticals Receives Positive Response From FDA Meeting Regarding Proposed in Vitro Bridging Strategy for Ad04","url":"https://stock-news.laohu8.com/highlight/detail?id=2514850092","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514850092?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:00","pubTimestamp":1740492002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA8ZSHD9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2514092845","title":"Adial Pharmaceuticals- Moves Forward With Manufacturing Clinical Supplies for Phase 3 Program in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514092845","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514092845?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:00","pubTimestamp":1740492002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA8ZSHD9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2514092565","title":"Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04","url":"https://stock-news.laohu8.com/highlight/detail?id=2514092565","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514092565?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:00","pubTimestamp":1740492000,"startTime":"0","endTime":"0","summary":"FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for the 505(b)(2) regulatory registration pathway for approval Adial mo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/25/3032060/26135/en/Adial-Pharmaceuticals-Receives-Positive-Response-from-FDA-Meeting-Regarding-Proposed-In-Vitro-Bridging-Strategy-for-AD04.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","STRK","LU2238339852.HKD","BK4595","BK4007","BK4516","BK4596","LU0426412945.USD","LU0994945656.USD","LU1043141123.HKD","BK4585","LU0345774631.USD","BK4023","LU0426417589.USD","BK4600","BK4588","AUD","BK4125"],"gpt_icon":1},{"id":"2514091051","title":"EXCLUSIVE: After FDA Response, Adial Starts Manufacturing Clinical Supplies For Upcoming Phase 3 Program Of Lead Candidate For Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2514091051","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514091051?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:30","pubTimestamp":1740490224,"startTime":"0","endTime":"0","summary":"On Tuesday, Adial Pharmaceuticals, Inc.  announced a positive response from the U.S. Food and Drug Administration  regarding its proposed in vitro bridging strategy for AD04.The FDA's feedback follows Adial's submission in November 2024, in which the company sought FDA's guidance on the alignment of its AD04 formulation strategy and bridging approach.The company also aimed to secure confirmation from the FDA that its proposed data package would meet the necessary bridging requirements and allow for the progression of AD04 into Phase 3 trials.In response, the FDA agreed with Adial's proposed 505 bridging strategy, which involves leveraging the results from AD04-103—a relative bioavailability food-effect study—along with in vitro dissolution data demonstrating equivalence between the reference product and the planned commercial formulation of AD04.While the final determination will depend on a comprehensive review of the complete New Drug Application , the FDA's agreement signals a signi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-fda-response-adial-starts-133024607.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4007","ADIL","BK4218","PK"],"gpt_icon":0},{"id":"2512489381","title":"BRIEF-Adial Pharmaceuticals Granted New U.S. Patent On Method To Identify Genetic Markers In Alcohol or Opioid-Related Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2512489381","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512489381?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:42","pubTimestamp":1739979768,"startTime":"0","endTime":"0","summary":"BRIEF-Adial Pharmaceuticals Granted New U.S. Patent On Method To Identify Genetic Markers In Alcohol or Opioid-Related DisordersFeb 19  - Adial Pharmaceuticals Inc ADIL.O:ADIAL PHARMACEUTICALS GRANTED NEW U.S. PATENT EXPANDING COVERAGE OF ITS GENETIC-BASED APPROACH TO TREATING AND DIAGNOSING ALCOHOL USE DISORDER AND OTHER DRUG DEPENDENCIESSource text: nGNX41V4YBFurther company coverage: ADIL.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2512274107","title":"Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of Its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies","url":"https://stock-news.laohu8.com/highlight/detail?id=2512274107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512274107?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:00","pubTimestamp":1739973659,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2512008841","title":"Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies","url":"https://stock-news.laohu8.com/highlight/detail?id=2512008841","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512008841?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:00","pubTimestamp":1739973600,"startTime":"0","endTime":"0","summary":"New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders Patent expands the identification of potential treatment candidates ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/19/3028804/26135/en/Adial-Pharmaceuticals-Granted-New-U-S-Patent-Expanding-Coverage-of-its-Genetic-Based-Approach-to-Treating-and-Diagnosing-Alcohol-Use-Disorder-and-Other-Drug-Dependencies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2238339852.HKD","LU0426417589.USD","AUD","LU1043141123.HKD","GENE","ADIL","BK4121","LU0426412945.USD","BK4007","LU0994945656.USD","BK4125","LU0345774631.USD"],"gpt_icon":0},{"id":"2510775023","title":"Adial Pharmaceuticals awarded new U.S. patent on genotype-specific treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2510775023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510775023?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:09","pubTimestamp":1739369377,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals (ADIL) announced patent number 12,221,654 was issued on February 11, 2025, by the United States Patent and Trademark Office. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-awarded-new-u-s-patent-on-genotype-specific-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-awarded-new-u-s-patent-on-genotype-specific-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":60,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADIL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-04","symbol":"ADIL","fiscalQuarterEnding":"2024/12","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2024-11-13","symbol":"ADIL","fiscalQuarterEnding":"2024/09","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2024-08-13","symbol":"ADIL","fiscalQuarterEnding":"2024/06","expectedEps":-0.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2024-05-14","symbol":"ADIL","fiscalQuarterEnding":"2024/03","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.68},{"date":"2024-04-01","symbol":"ADIL","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1712001600000,"name":null,"time":"Post Market","dateTimestamp":1711944000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADIL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADIL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1721793600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADIL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADIL","date":"2025-05-02","current":-0.388573,"percent":0.885621,"low":-5.938699,"twenty":-3.228855,"median":-0.848849,"eighty":-0.476712,"high":-0.224751,"avg":-1.739031,"sd":1.446676,"marketCap":5128178},"quantilePoints":[{"date":"2020-05-08","current":-1.651707,"twenty":-3.791204,"median":-2.099876,"eighty":-1.506053,"marketCap":14190520},{"date":"2020-05-15","current":-1.766062,"twenty":-3.781443,"median":-2.088939,"eighty":-1.511461,"marketCap":14456260},{"date":"2020-05-22","current":-1.960848,"twenty":-3.75683,"median":-2.063671,"eighty":-1.51252,"marketCap":16050700},{"date":"2020-05-29","current":-2.097328,"twenty":-3.725401,"median":-2.07772,"eighty":-1.51252,"marketCap":17167871},{"date":"2020-06-05","current":-2.234068,"twenty":-3.66101,"median":-2.076729,"eighty":-1.51252,"marketCap":18287169},{"date":"2020-06-12","current":-2.431762,"twenty":-3.59988,"median":-2.075739,"eighty":-1.522278,"marketCap":19905412},{"date":"2020-06-19","current":-2.415332,"twenty":-3.576122,"median":-2.088939,"eighty":-1.538354,"marketCap":19770916},{"date":"2020-06-26","current":-2.283885,"twenty":-3.554036,"median":-2.097802,"eighty":-1.547249,"marketCap":18694948},{"date":"2020-07-02","current":-2.267454,"twenty":-3.539758,"median":-2.116786,"eighty":-1.559253,"marketCap":18560452},{"date":"2020-07-10","current":-2.333177,"twenty":-3.496836,"median":-2.126837,"eighty":-1.569668,"marketCap":19098436},{"date":"2020-07-17","current":-2.333177,"twenty":-3.485743,"median":-2.135771,"eighty":-1.581894,"marketCap":19098436},{"date":"2020-07-24","current":-2.300316,"twenty":-3.461368,"median":-2.145263,"eighty":-1.585706,"marketCap":18829444},{"date":"2020-07-31","current":-2.645363,"twenty":-3.4506,"median":-2.164248,"eighty":-1.587507,"marketCap":21653860},{"date":"2020-08-07","current":-3.056134,"twenty":-3.435084,"median":-2.184266,"eighty":-1.594835,"marketCap":25016261},{"date":"2020-08-14","current":-2.673454,"twenty":-3.405207,"median":-2.207577,"eighty":-1.595338,"marketCap":21019483},{"date":"2020-08-21","current":-2.518221,"twenty":-3.396604,"median":-2.219225,"eighty":-1.597111,"marketCap":19798997},{"date":"2020-08-28","current":-2.328492,"twenty":-3.392861,"median":-2.234068,"eighty":-1.604328,"marketCap":18307291},{"date":"2020-09-04","current":-2.242252,"twenty":-3.37789,"median":-2.236218,"eighty":-1.604883,"marketCap":17629244},{"date":"2020-09-11","current":-2.190508,"twenty":-3.37789,"median":-2.234818,"eighty":-1.605077,"marketCap":17222415},{"date":"2020-09-18","current":-2.276748,"twenty":-3.374907,"median":-2.242252,"eighty":-1.608403,"marketCap":17900463},{"date":"2020-09-25","current":-2.087019,"twenty":-3.368533,"median":-2.236218,"eighty":-1.610468,"marketCap":16408757},{"date":"2020-10-02","current":-3.787402,"twenty":-3.37789,"median":-2.242252,"eighty":-1.613694,"marketCap":29777667},{"date":"2020-10-09","current":-3.559456,"twenty":-3.442015,"median":-2.252098,"eighty":-1.617146,"marketCap":27985492},{"date":"2020-10-16","current":-3.296442,"twenty":-3.454251,"median":-2.265714,"eighty":-1.620776,"marketCap":25917599},{"date":"2020-10-23","current":-3.156168,"twenty":-3.452746,"median":-2.267454,"eighty":-1.629214,"marketCap":24814722},{"date":"2020-10-30","current":-3.050963,"twenty":-3.442015,"median":-2.276748,"eighty":-1.634497,"marketCap":23987565},{"date":"2020-11-06","current":-3.208771,"twenty":-3.407358,"median":-2.280317,"eighty":-1.651707,"marketCap":25228301},{"date":"2020-11-13","current":-2.758982,"twenty":-3.407358,"median":-2.293996,"eighty":-1.65335,"marketCap":26161304},{"date":"2020-11-20","current":-2.594043,"twenty":-3.401648,"median":-2.297156,"eighty":-1.657893,"marketCap":24597313},{"date":"2020-11-27","current":-2.923921,"twenty":-3.397613,"median":-2.300316,"eighty":-1.667791,"marketCap":27725295},{"date":"2020-12-04","current":-3.081342,"twenty":-3.397613,"median":-2.314066,"eighty":-1.673036,"marketCap":29217993},{"date":"2020-12-11","current":-3.005447,"twenty":-3.396604,"median":-2.333095,"eighty":-1.679388,"marketCap":28498338},{"date":"2020-12-18","current":-2.762582,"twenty":-3.386612,"median":-2.333177,"eighty":-1.68227,"marketCap":26195442},{"date":"2020-12-24","current":-2.732224,"twenty":-3.38038,"median":-2.341393,"eighty":-1.683028,"marketCap":25907580},{"date":"2020-12-31","current":-2.580434,"twenty":-3.37789,"median":-2.349608,"eighty":-1.683288,"marketCap":24468270},{"date":"2021-01-08","current":-2.929552,"twenty":-3.376697,"median":-2.371742,"eighty":-1.685826,"marketCap":27778683},{"date":"2021-01-15","current":-2.914373,"twenty":-3.372357,"median":-2.38247,"eighty":-1.691783,"marketCap":27634752},{"date":"2021-01-22","current":-3.369743,"twenty":-3.373874,"median":-2.398901,"eighty":-1.695833,"marketCap":31952682},{"date":"2021-01-29","current":-3.26349,"twenty":-3.377293,"median":-2.412622,"eighty":-1.69944,"marketCap":30945165},{"date":"2021-02-05","current":-4.250127,"twenty":-3.382869,"median":-2.415332,"eighty":-1.700885,"marketCap":40300680},{"date":"2021-02-12","current":-4.819742,"twenty":-3.406216,"median":-2.425718,"eighty":-1.70215,"marketCap":45701901},{"date":"2021-02-19","current":-4.739945,"twenty":-3.452746,"median":-2.431762,"eighty":-1.704258,"marketCap":44945247},{"date":"2021-02-26","current":-4.005812,"twenty":-3.471785,"median":-2.431762,"eighty":-1.705101,"marketCap":37984030},{"date":"2021-03-05","current":-3.399354,"twenty":-3.489319,"median":-2.441435,"eighty":-1.705101,"marketCap":32233460},{"date":"2021-03-12","current":-4.101568,"twenty":-3.498221,"median":-2.464624,"eighty":-1.705101,"marketCap":38892015},{"date":"2021-03-19","current":-4.05369,"twenty":-3.559456,"median":-2.47723,"eighty":-1.707506,"marketCap":38438023},{"date":"2021-03-26","current":-3.789135,"twenty":-3.589115,"median":-2.497486,"eighty":-1.709291,"marketCap":41275006},{"date":"2021-04-01","current":-3.836697,"twenty":-3.646448,"median":-2.533293,"eighty":-1.709291,"marketCap":41793102},{"date":"2021-04-09","current":-3.773281,"twenty":-3.701292,"median":-2.536911,"eighty":-1.716345,"marketCap":41102307},{"date":"2021-04-16","current":-3.472052,"twenty":-3.685153,"median":-2.546778,"eighty":-1.719425,"marketCap":37821030},{"date":"2021-04-23","current":-3.519026,"twenty":-3.682196,"median":-2.555594,"eighty":-1.722647,"marketCap":38332713},{"date":"2021-04-30","current":-3.535094,"twenty":-3.666281,"median":-2.567809,"eighty":-1.734349,"marketCap":38507748},{"date":"2021-05-07","current":-3.486889,"twenty":-3.682196,"median":-2.575354,"eighty":-1.737642,"marketCap":37982642},{"date":"2021-05-14","current":-3.776124,"twenty":-3.682196,"median":-2.587214,"eighty":-1.737818,"marketCap":41133276},{"date":"2021-05-21","current":-3.279485,"twenty":-3.680209,"median":-2.604462,"eighty":-1.737828,"marketCap":44108875},{"date":"2021-05-28","current":-3.214416,"twenty":-3.665784,"median":-2.610792,"eighty":-1.742987,"marketCap":43233699},{"date":"2021-06-04","current":-3.719373,"twenty":-3.673825,"median":-2.618548,"eighty":-1.745662,"marketCap":50025351},{"date":"2021-06-11","current":-3.775304,"twenty":-3.69626,"median":-2.631039,"eighty":-1.752281,"marketCap":50777612},{"date":"2021-06-18","current":-4.082921,"twenty":-3.729363,"median":-2.645363,"eighty":-1.756078,"marketCap":54915047},{"date":"2021-06-25","current":-3.393784,"twenty":-3.758224,"median":-2.665661,"eighty":-1.756078,"marketCap":45646200},{"date":"2021-07-02","current":-4.023277,"twenty":-3.758224,"median":-2.671508,"eighty":-1.756494,"marketCap":54112834},{"date":"2021-07-09","current":-3.804323,"twenty":-3.773281,"median":-2.671655,"eighty":-1.758849,"marketCap":51167918},{"date":"2021-07-16","current":-3.462207,"twenty":-3.771916,"median":-2.714066,"eighty":-1.763087,"marketCap":46566486},{"date":"2021-07-23","current":-3.340356,"twenty":-3.762105,"median":-2.725886,"eighty":-1.765286,"marketCap":44927592},{"date":"2021-07-30","current":-3.410238,"twenty":-3.75011,"median":-2.732239,"eighty":-1.766062,"marketCap":45867500},{"date":"2021-08-06","current":-4.184276,"twenty":-3.762105,"median":-2.743948,"eighty":-1.766144,"marketCap":56278266},{"date":"2021-08-13","current":-4.14048,"twenty":-3.775304,"median":-2.745583,"eighty":-1.766267,"marketCap":66577951},{"date":"2021-08-20","current":-4.216221,"twenty":-3.776622,"median":-2.758982,"eighty":-1.767458,"marketCap":67795841},{"date":"2021-08-27","current":-5.341014,"twenty":-3.789822,"median":-2.762582,"eighty":-1.771572,"marketCap":85882255},{"date":"2021-09-03","current":-5.531765,"twenty":-3.803901,"median":-2.762582,"eighty":-1.775343,"marketCap":88949478},{"date":"2021-09-10","current":-5.264714,"twenty":-3.816661,"median":-2.766059,"eighty":-1.777521,"marketCap":84655365},{"date":"2021-09-17","current":-5.328298,"twenty":-3.843513,"median":-2.780875,"eighty":-1.785204,"marketCap":85677773},{"date":"2021-09-24","current":-5.887832,"twenty":-3.867058,"median":-2.788397,"eighty":-1.789142,"marketCap":94674962},{"date":"2021-10-01","current":-5.302864,"twenty":-3.899737,"median":-2.791864,"eighty":-1.79489,"marketCap":85268810},{"date":"2021-10-08","current":-4.705179,"twenty":-3.938366,"median":-2.80812,"eighty":-1.798007,"marketCap":75658177},{"date":"2021-10-15","current":-4.93408,"twenty":-3.968422,"median":-2.814865,"eighty":-1.807906,"marketCap":79338845},{"date":"2021-10-22","current":-4.425412,"twenty":-3.993148,"median":-2.823299,"eighty":-1.822525,"marketCap":71159582},{"date":"2021-10-29","current":-4.082061,"twenty":-4.020904,"median":-2.855141,"eighty":-1.822525,"marketCap":65638580},{"date":"2021-11-05","current":-3.81501,"twenty":-4.022976,"median":-2.875395,"eighty":-1.822843,"marketCap":61344468},{"date":"2021-11-12","current":-4.183795,"twenty":-4.037833,"median":-2.905482,"eighty":-1.82457,"marketCap":67274433},{"date":"2021-11-19","current":-3.675798,"twenty":-4.029611,"median":-2.910038,"eighty":-1.826489,"marketCap":62715470},{"date":"2021-11-26","current":-3.468882,"twenty":-4.023277,"median":-2.914373,"eighty":-1.826894,"marketCap":59185129},{"date":"2021-12-03","current":-3.249795,"twenty":-4.023277,"median":-2.929552,"eighty":-1.82834,"marketCap":55447121},{"date":"2021-12-10","current":-3.347167,"twenty":-4.021771,"median":-2.97375,"eighty":-1.830512,"marketCap":57108458},{"date":"2021-12-17","current":-3.228855,"twenty":-4.017437,"median":-2.991129,"eighty":-1.831105,"marketCap":55089852},{"date":"2021-12-23","current":-3.41301,"twenty":-4.016767,"median":-3.001904,"eighty":-1.831835,"marketCap":58231859},{"date":"2021-12-31","current":-3.314794,"twenty":-4.013726,"median":-3.011455,"eighty":-1.832017,"marketCap":56556122},{"date":"2022-01-07","current":-3.179747,"twenty":-4.007251,"median":-3.019917,"eighty":-1.834356,"marketCap":54251984},{"date":"2022-01-14","current":-3.216578,"twenty":-4.005771,"median":-3.023272,"eighty":-1.837621,"marketCap":54880385},{"date":"2022-01-21","current":-2.872822,"twenty":-3.998688,"median":-3.028551,"eighty":-1.845918,"marketCap":49015306},{"date":"2022-01-28","current":-2.639558,"twenty":-3.993415,"median":-3.020626,"eighty":-1.851002,"marketCap":45035430},{"date":"2022-02-04","current":-2.946484,"twenty":-3.991129,"median":-3.014375,"eighty":-1.85131,"marketCap":50272108},{"date":"2022-02-11","current":-2.664112,"twenty":-3.983572,"median":-3.008451,"eighty":-1.855713,"marketCap":45454365},{"date":"2022-02-18","current":-2.795811,"twenty":-3.979384,"median":-2.99836,"eighty":-1.860141,"marketCap":47701372},{"date":"2022-02-25","current":-2.891585,"twenty":-3.976134,"median":-2.995592,"eighty":-1.862633,"marketCap":49335440},{"date":"2022-03-04","current":-2.613548,"twenty":-3.965586,"median":-2.976958,"eighty":-1.866653,"marketCap":44591648},{"date":"2022-03-11","current":-2.599646,"twenty":-3.952331,"median":-2.973106,"eighty":-1.870003,"marketCap":44354458},{"date":"2022-03-18","current":-2.613548,"twenty":-3.944364,"median":-2.946484,"eighty":-1.870724,"marketCap":44591648},{"date":"2022-03-25","current":-2.835977,"twenty":-3.941259,"median":-2.94583,"eighty":-1.873621,"marketCap":48386682},{"date":"2022-04-01","current":-2.478952,"twenty":-3.938226,"median":-2.930872,"eighty":-1.878495,"marketCap":48149492},{"date":"2022-04-08","current":-1.978277,"twenty":-3.934469,"median":-2.923921,"eighty":-1.879365,"marketCap":38424718},{"date":"2022-04-14","current":-2.137028,"twenty":-3.928634,"median":-2.914373,"eighty":-1.879627,"marketCap":41508183},{"date":"2022-04-22","current":-2.0027,"twenty":-3.922913,"median":-2.908596,"eighty":-1.88032,"marketCap":38899097},{"date":"2022-04-29","current":-1.721834,"twenty":-3.910837,"median":-2.898226,"eighty":-1.879327,"marketCap":33443736},{"date":"2022-05-06","current":-1.624141,"twenty":-3.899737,"median":-2.888342,"eighty":-1.869762,"marketCap":31546219},{"date":"2022-05-13","current":-1.563083,"twenty":-3.892563,"median":-2.875395,"eighty":-1.852915,"marketCap":30360271},{"date":"2022-05-20","current":-1.849017,"twenty":-3.886405,"median":-2.866948,"eighty":-1.851105,"marketCap":32352988},{"date":"2022-05-27","current":-1.726655,"twenty":-3.885585,"median":-2.856625,"eighty":-1.849017,"marketCap":30211981},{"date":"2022-06-03","current":-1.821825,"twenty":-3.882714,"median":-2.835977,"eighty":-1.834941,"marketCap":31877209},{"date":"2022-06-10","current":-1.862612,"twenty":-3.868405,"median":-2.819883,"eighty":-1.838291,"marketCap":32590877},{"date":"2022-06-17","current":-1.767442,"twenty":-3.861672,"median":-2.813262,"eighty":-1.831738,"marketCap":30925650},{"date":"2022-06-24","current":-1.744728,"twenty":-3.854375,"median":-2.811436,"eighty":-1.828051,"marketCap":30528214},{"date":"2022-07-01","current":-1.75939,"twenty":-3.847569,"median":-2.80364,"eighty":-1.825934,"marketCap":30784754},{"date":"2022-07-08","current":-1.862021,"twenty":-3.846249,"median":-2.795096,"eighty":-1.825479,"marketCap":32580531},{"date":"2022-07-15","current":-2.389838,"twenty":-3.84561,"median":-2.79294,"eighty":-1.826692,"marketCap":41815958},{"date":"2022-07-22","current":-1.08525,"twenty":-3.840105,"median":-2.788397,"eighty":-1.82348,"marketCap":18989062},{"date":"2022-07-29","current":-0.953003,"twenty":-3.836697,"median":-2.78494,"eighty":-1.820309,"marketCap":16675075},{"date":"2022-08-05","current":-0.886954,"twenty":-3.836697,"median":-2.775393,"eighty":-1.803901,"marketCap":15519389},{"date":"2022-08-12","current":-0.843224,"twenty":-3.825029,"median":-2.766059,"eighty":-1.791821,"marketCap":14754234},{"date":"2022-08-19","current":-0.90238,"twenty":-3.815906,"median":-2.762582,"eighty":-1.778928,"marketCap":15253837},{"date":"2022-08-26","current":-0.879819,"twenty":-3.814583,"median":-2.762328,"eighty":-1.766972,"marketCap":14872465},{"date":"2022-09-02","current":-0.806858,"twenty":-3.808681,"median":-2.754976,"eighty":-1.765545,"marketCap":13639127},{"date":"2022-09-09","current":-0.82608,"twenty":-3.804691,"median":-2.748614,"eighty":-1.757819,"marketCap":13964060},{"date":"2022-09-16","current":-0.715195,"twenty":-3.803901,"median":-2.743948,"eighty":-1.750383,"marketCap":12089653},{"date":"2022-09-23","current":-0.597002,"twenty":-3.803265,"median":-2.734996,"eighty":-1.741861,"marketCap":10091718},{"date":"2022-09-30","current":-0.556016,"twenty":-3.798992,"median":-2.728298,"eighty":-1.737368,"marketCap":9398886},{"date":"2022-10-07","current":-0.559352,"twenty":-3.791666,"median":-2.722371,"eighty":-1.726655,"marketCap":9455280},{"date":"2022-10-14","current":-0.519477,"twenty":-3.789822,"median":-2.711086,"eighty":-1.718767,"marketCap":8781245},{"date":"2022-10-21","current":-0.461175,"twenty":-3.789135,"median":-2.700643,"eighty":-1.709291,"marketCap":7795705},{"date":"2022-10-28","current":-0.492471,"twenty":-3.788442,"median":-2.683057,"eighty":-1.705101,"marketCap":8324728},{"date":"2022-11-04","current":-0.486593,"twenty":-3.783223,"median":-2.671655,"eighty":-1.699959,"marketCap":8225368},{"date":"2022-11-11","current":-0.443224,"twenty":-3.776622,"median":-2.671508,"eighty":-1.691783,"marketCap":7492255},{"date":"2022-11-18","current":-0.496853,"twenty":-3.775895,"median":-2.664886,"eighty":-1.681537,"marketCap":7798390},{"date":"2022-11-25","current":-0.479059,"twenty":-3.775502,"median":-2.65573,"eighty":-1.670667,"marketCap":7519109},{"date":"2022-12-02","current":-0.444841,"twenty":-3.775304,"median":-2.645363,"eighty":-1.652036,"marketCap":6982030},{"date":"2022-12-09","current":-0.381537,"twenty":-3.775304,"median":-2.639322,"eighty":-1.630271,"marketCap":5988433},{"date":"2022-12-16","current":-0.427903,"twenty":-3.774899,"median":-2.625971,"eighty":-1.614384,"marketCap":6716175},{"date":"2022-12-23","current":-0.378115,"twenty":-3.773281,"median":-2.61678,"eighty":-1.604883,"marketCap":5934725},{"date":"2022-12-30","current":-0.367849,"twenty":-3.773281,"median":-2.613548,"eighty":-1.595338,"marketCap":5773601},{"date":"2023-01-06","current":-0.598995,"twenty":-3.770551,"median":-2.608181,"eighty":-1.585706,"marketCap":9401572},{"date":"2023-01-13","current":-0.547668,"twenty":-3.754342,"median":-2.604462,"eighty":-1.566097,"marketCap":8595953},{"date":"2023-01-20","current":-0.581544,"twenty":-3.749935,"median":-2.601068,"eighty":-1.539073,"marketCap":9127661},{"date":"2023-01-27","current":-0.532098,"twenty":-3.74913,"median":-2.590629,"eighty":-1.51252,"marketCap":8351582},{"date":"2023-02-03","current":-0.719102,"twenty":-3.74614,"median":-2.580434,"eighty":-1.491234,"marketCap":11286720},{"date":"2023-02-10","current":-0.598824,"twenty":-3.73928,"median":-2.571098,"eighty":-1.459695,"marketCap":9398886},{"date":"2023-02-17","current":-0.738094,"twenty":-3.7359,"median":-2.565777,"eighty":-1.432955,"marketCap":11584799},{"date":"2023-02-24","current":-0.908246,"twenty":-3.729289,"median":-2.558469,"eighty":-1.287296,"marketCap":14255430},{"date":"2023-03-03","current":-0.763079,"twenty":-3.719041,"median":-2.551917,"eighty":-1.229513,"marketCap":11976956},{"date":"2023-03-10","current":-0.872272,"twenty":-3.715865,"median":-2.546778,"eighty":-1.205236,"marketCap":13690802},{"date":"2023-03-17","current":-0.74491,"twenty":-3.705901,"median":-2.541764,"eighty":-1.200932,"marketCap":11691791},{"date":"2023-03-24","current":-0.639896,"twenty":-3.696499,"median":-2.534333,"eighty":-1.190888,"marketCap":10043533},{"date":"2023-03-31","current":-0.78395,"twenty":-3.690346,"median":-2.530546,"eighty":-1.166496,"marketCap":9980797},{"date":"2023-04-06","current":-0.711827,"twenty":-3.682196,"median":-2.510277,"eighty":-1.162192,"marketCap":9062564},{"date":"2023-04-14","current":-0.671957,"twenty":-3.681699,"median":-2.497486,"eighty":-1.155018,"marketCap":8554969},{"date":"2023-04-21","current":-0.584827,"twenty":-3.678929,"median":-2.480004,"eighty":-1.14067,"marketCap":7445674},{"date":"2023-04-28","current":-0.761104,"twenty":-3.674618,"median":-2.466477,"eighty":-1.122017,"marketCap":9689928},{"date":"2023-05-05","current":-0.673077,"twenty":-3.6699,"median":-2.454529,"eighty":-1.119148,"marketCap":8569227},{"date":"2023-05-12","current":-0.714067,"twenty":-3.662302,"median":-2.4437,"eighty":-1.111974,"marketCap":9091080},{"date":"2023-05-18","current":-0.74823,"twenty":-3.65073,"median":-2.434884,"eighty":-1.103724,"marketCap":9524532},{"date":"2023-05-26","current":-0.586039,"twenty":-3.647004,"median":-2.431762,"eighty":-1.097626,"marketCap":7459933},{"date":"2023-06-02","current":-0.59948,"twenty":-3.646448,"median":-2.431762,"eighty":-1.087331,"marketCap":7631032},{"date":"2023-06-09","current":-0.59276,"twenty":-3.643367,"median":-2.425718,"eighty":-1.06893,"marketCap":7545482},{"date":"2023-06-16","current":-0.548852,"twenty":-3.636281,"median":-2.415332,"eighty":-1.056017,"marketCap":6986558},{"date":"2023-06-23","current":-0.564525,"twenty":-3.626423,"median":-2.414733,"eighty":-1.043821,"marketCap":7186075},{"date":"2023-06-30","current":-0.502663,"twenty":-3.621192,"median":-2.407321,"eighty":-1.040234,"marketCap":6398601},{"date":"2023-07-07","current":-0.504074,"twenty":-3.612187,"median":-2.398901,"eighty":-1.03019,"marketCap":6416566},{"date":"2023-07-14","current":-0.682605,"twenty":-3.603981,"median":-2.393471,"eighty":-1.020599,"marketCap":8689163},{"date":"2023-07-21","current":-0.648498,"twenty":-3.595267,"median":-2.381354,"eighty":-0.936577,"marketCap":8255004},{"date":"2023-07-28","current":-0.618626,"twenty":-3.58398,"median":-2.363079,"eighty":-0.903593,"marketCap":7874741},{"date":"2023-08-04","current":-0.576757,"twenty":-3.567071,"median":-2.338424,"eighty":-0.90116,"marketCap":7341773},{"date":"2023-08-11","current":-0.449738,"twenty":-3.551892,"median":-2.328492,"eighty":-0.879439,"marketCap":5724905},{"date":"2023-08-18","current":-0.307666,"twenty":-3.498949,"median":-2.300316,"eighty":-0.871791,"marketCap":3916410},{"date":"2023-08-25","current":-0.529755,"twenty":-3.489577,"median":-2.283885,"eighty":-0.851252,"marketCap":4128955},{"date":"2023-09-01","current":-0.684463,"twenty":-3.472052,"median":-2.267454,"eighty":-0.842685,"marketCap":5334756},{"date":"2023-09-08","current":-0.542257,"twenty":-3.463523,"median":-2.262791,"eighty":-0.828747,"marketCap":4226394},{"date":"2023-09-15","current":-0.453183,"twenty":-3.454751,"median":-2.242252,"eighty":-0.821013,"marketCap":3532144},{"date":"2023-09-22","current":-0.395363,"twenty":-3.447233,"median":-2.234068,"eighty":-0.81269,"marketCap":3081491},{"date":"2023-09-29","current":-0.403177,"twenty":-3.41528,"median":-2.216631,"eighty":-0.804685,"marketCap":3142390},{"date":"2023-10-06","current":-0.432868,"twenty":-3.401648,"median":-2.196422,"eighty":-0.799416,"marketCap":3373807},{"date":"2023-10-13","current":-0.457871,"twenty":-3.388456,"median":-2.173259,"eighty":-0.78395,"marketCap":3568684},{"date":"2023-10-20","current":-0.440682,"twenty":-3.380759,"median":-2.145263,"eighty":-0.770668,"marketCap":3434706},{"date":"2023-10-27","current":-0.318791,"twenty":-3.373828,"median":-2.137028,"eighty":-0.76332,"marketCap":2484681},{"date":"2023-11-03","current":-0.367235,"twenty":-3.354518,"median":-2.124816,"eighty":-0.757878,"marketCap":2862255},{"date":"2023-11-10","current":-0.310977,"twenty":-3.346924,"median":-2.097802,"eighty":-0.752854,"marketCap":2423782},{"date":"2023-11-17","current":-0.409358,"twenty":-3.346924,"median":-2.089568,"eighty":-0.739251,"marketCap":2484681},{"date":"2023-11-24","current":-0.425411,"twenty":-3.346924,"median":-2.089568,"eighty":-0.72885,"marketCap":2582119},{"date":"2023-12-01","current":-0.439458,"twenty":-3.346924,"median":-2.088309,"eighty":-0.717672,"marketCap":2667378},{"date":"2023-12-08","current":-0.405345,"twenty":-3.346682,"median":-2.087664,"eighty":-0.712723,"marketCap":2460321},{"date":"2023-12-15","current":-0.367639,"twenty":-3.346682,"median":-2.082369,"eighty":-0.68894,"marketCap":2231462},{"date":"2023-12-22","current":-0.372837,"twenty":-3.346924,"median":-2.075739,"eighty":-0.682206,"marketCap":2263008},{"date":"2023-12-29","current":-0.355178,"twenty":-3.340356,"median":-2.051675,"eighty":-0.674975,"marketCap":2155826},{"date":"2024-01-05","current":-0.345145,"twenty":-3.329526,"median":-2.049893,"eighty":-0.671957,"marketCap":2094927},{"date":"2024-01-12","current":-0.317052,"twenty":-3.310238,"median":-2.038763,"eighty":-0.667169,"marketCap":1924409},{"date":"2024-01-19","current":-0.356625,"twenty":-3.291143,"median":-2.023812,"eighty":-0.663703,"marketCap":2164609},{"date":"2024-01-26","current":-0.339826,"twenty":-3.27797,"median":-2.0027,"eighty":-0.655671,"marketCap":2062642},{"date":"2024-02-02","current":-0.315161,"twenty":-3.266497,"median":-1.996992,"eighty":-0.649506,"marketCap":1912934},{"date":"2024-02-09","current":-0.322807,"twenty":-3.257592,"median":-1.978277,"eighty":-0.640004,"marketCap":1959343},{"date":"2024-02-16","current":-0.317902,"twenty":-3.254065,"median":-1.944187,"eighty":-0.627689,"marketCap":1929568},{"date":"2024-02-23","current":-0.230205,"twenty":-3.254065,"median":-1.936432,"eighty":-0.624687,"marketCap":1397273},{"date":"2024-03-01","current":-0.559068,"twenty":-3.245859,"median":-1.918528,"eighty":-0.616542,"marketCap":3393378},{"date":"2024-03-08","current":-0.580993,"twenty":-3.241132,"median":-1.907746,"eighty":-0.613841,"marketCap":3526452},{"date":"2024-03-15","current":-0.476852,"twenty":-3.231711,"median":-1.897614,"eighty":-0.6006,"marketCap":2894352},{"date":"2024-03-22","current":-0.468631,"twenty":-3.231711,"median":-1.889804,"eighty":-0.597002,"marketCap":2844449},{"date":"2024-03-28","current":-0.383674,"twenty":-3.231711,"median":-1.881826,"eighty":-0.589175,"marketCap":2328789},{"date":"2024-04-05","current":-0.396103,"twenty":-3.231115,"median":-1.876683,"eighty":-0.583477,"marketCap":2029373},{"date":"2024-04-12","current":-2.358517,"twenty":-3.231115,"median":-1.862612,"eighty":-0.582307,"marketCap":12083485},{"date":"2024-04-19","current":-1.717443,"twenty":-3.231115,"median":-1.862021,"eighty":-0.582307,"marketCap":8799048},{"date":"2024-04-26","current":-1.369206,"twenty":-3.228855,"median":-1.851002,"eighty":-0.582455,"marketCap":7014909},{"date":"2024-05-03","current":-1.416693,"twenty":-3.228855,"median":-1.841183,"eighty":-0.582455,"marketCap":7258201},{"date":"2024-05-10","current":-1.30589,"twenty":-3.228855,"median":-1.832017,"eighty":-0.582455,"marketCap":6690520},{"date":"2024-05-17","current":-0.657616,"twenty":-3.228855,"median":-1.827364,"eighty":-0.582455,"marketCap":5717354},{"date":"2024-05-24","current":-0.582993,"twenty":-3.228855,"median":-1.822175,"eighty":-0.582455,"marketCap":5068576},{"date":"2024-05-31","current":-0.676271,"twenty":-3.228855,"median":-1.805783,"eighty":-0.581544,"marketCap":5879548},{"date":"2024-06-07","current":-0.582993,"twenty":-3.228855,"median":-1.799005,"eighty":-0.581544,"marketCap":5068576},{"date":"2024-06-14","current":-0.632021,"twenty":-3.231115,"median":-1.781038,"eighty":-0.580598,"marketCap":5494833},{"date":"2024-06-21","current":-0.535611,"twenty":-3.233374,"median":-1.771044,"eighty":-0.57837,"marketCap":4656638},{"date":"2024-06-28","current":-0.545349,"twenty":-3.240153,"median":-1.769244,"eighty":-0.576757,"marketCap":4741304},{"date":"2024-07-05","current":-0.508831,"twenty":-3.240153,"median":-1.769244,"eighty":-0.571902,"marketCap":4423806},{"date":"2024-07-12","current":-0.555088,"twenty":-3.240153,"median":-1.766267,"eighty":-0.564594,"marketCap":4825971},{"date":"2024-07-15","current":-0.550219,"twenty":-3.240153,"median":-1.766062,"eighty":-0.564549,"marketCap":4783638},{"date":"2024-08-02","current":-0.496658,"twenty":-3.243968,"median":-1.760677,"eighty":-0.559995,"marketCap":4317974},{"date":"2024-08-09","current":-0.477181,"twenty":-3.243968,"median":-1.760677,"eighty":-0.556127,"marketCap":4148641},{"date":"2024-08-16","current":-0.335167,"twenty":-3.243968,"median":-1.760677,"eighty":-0.548994,"marketCap":4102498},{"date":"2024-08-23","current":-0.528324,"twenty":-3.243968,"median":-1.760677,"eighty":-0.546423,"marketCap":6466774},{"date":"2024-08-30","current":-0.51739,"twenty":-3.243968,"median":-1.760677,"eighty":-0.543687,"marketCap":6332943},{"date":"2024-09-06","current":-0.533608,"twenty":-3.243968,"median":-1.760677,"eighty":-0.539247,"marketCap":6531448},{"date":"2024-09-13","current":-0.570228,"twenty":-3.243968,"median":-1.760677,"eighty":-0.535459,"marketCap":6979685},{"date":"2024-09-20","current":-0.549302,"twenty":-3.243968,"median":-1.760677,"eighty":-0.535459,"marketCap":6723550},{"date":"2024-09-27","current":-0.523302,"twenty":-3.243968,"median":-1.760677,"eighty":-0.534308,"marketCap":6405302},{"date":"2024-10-04","current":-0.506195,"twenty":-3.243968,"median":-1.760677,"eighty":-0.529447,"marketCap":6195911},{"date":"2024-10-11","current":-0.496988,"twenty":-3.243968,"median":-1.760677,"eighty":-0.526824,"marketCap":6083211},{"date":"2024-10-18","current":-0.507503,"twenty":-3.243968,"median":-1.760677,"eighty":-0.523208,"marketCap":6211919},{"date":"2024-10-25","current":-0.575675,"twenty":-3.243968,"median":-1.760677,"eighty":-0.523208,"marketCap":7046359},{"date":"2024-10-31","current":-0.520986,"twenty":-3.243968,"median":-1.760677,"eighty":-0.523145,"marketCap":6376954},{"date":"2024-11-08","current":-0.559975,"twenty":-3.244914,"median":-1.761965,"eighty":-0.523145,"marketCap":6854185},{"date":"2024-11-15","current":-0.559714,"twenty":-3.244914,"median":-1.75939,"eighty":-0.522727,"marketCap":7302590},{"date":"2024-11-22","current":-0.500797,"twenty":-3.244914,"median":-1.737828,"eighty":-0.519669,"marketCap":6533896},{"date":"2024-11-29","current":-0.490978,"twenty":-3.244914,"median":-1.726655,"eighty":-0.517408,"marketCap":6405781},{"date":"2024-12-06","current":-0.564624,"twenty":-3.244914,"median":-1.71306,"eighty":-0.516264,"marketCap":7366648},{"date":"2024-12-13","current":-0.535165,"twenty":-3.244914,"median":-1.699464,"eighty":-0.516264,"marketCap":6982301},{"date":"2024-12-20","current":-0.515526,"twenty":-3.241132,"median":-1.682637,"eighty":-0.515753,"marketCap":6726070},{"date":"2024-12-27","current":-0.515526,"twenty":-3.241132,"median":-1.658677,"eighty":-0.515526,"marketCap":6726070},{"date":"2025-01-03","current":-0.520682,"twenty":-3.238677,"median":-1.642097,"eighty":-0.515304,"marketCap":6793330},{"date":"2025-01-10","current":-0.500797,"twenty":-3.228855,"median":-1.622459,"eighty":-0.514779,"marketCap":6533896},{"date":"2025-01-17","current":-0.510617,"twenty":-3.228855,"median":-1.596291,"eighty":-0.512566,"marketCap":6662012},{"date":"2025-01-24","current":-0.481158,"twenty":-3.228855,"median":-1.578118,"eighty":-0.509962,"marketCap":6277665},{"date":"2025-01-31","current":-0.407511,"twenty":-3.228855,"median":-1.520008,"eighty":-0.508758,"marketCap":5316798},{"date":"2025-02-07","current":-0.387872,"twenty":-3.228855,"median":-1.502037,"eighty":-0.506404,"marketCap":5060566},{"date":"2025-02-14","current":-0.38689,"twenty":-3.228855,"median":-1.461994,"eighty":-0.504074,"marketCap":5047755},{"date":"2025-02-21","current":-0.377562,"twenty":-3.228855,"median":-1.431986,"eighty":-0.501208,"marketCap":4926045},{"date":"2025-02-28","current":-0.378053,"twenty":-3.228855,"median":-1.361292,"eighty":-0.500797,"marketCap":4932451},{"date":"2025-03-07","current":-0.364035,"twenty":-3.228855,"median":-1.30589,"eighty":-0.497011,"marketCap":4804335},{"date":"2025-03-14","current":-0.333775,"twenty":-3.228855,"median":-1.258403,"eighty":-0.496814,"marketCap":4404973},{"date":"2025-03-21","current":-0.358185,"twenty":-3.228855,"median":-1.08525,"eighty":-0.495887,"marketCap":4727128},{"date":"2025-03-28","current":-0.323811,"twenty":-3.228855,"median":-0.908246,"eighty":-0.492389,"marketCap":4273482},{"date":"2025-04-04","current":-0.336166,"twenty":-3.228855,"median":-0.90238,"eighty":-0.490647,"marketCap":4436531},{"date":"2025-04-11","current":-0.356242,"twenty":-3.228855,"median":-0.890659,"eighty":-0.486433,"marketCap":4701487},{"date":"2025-04-17","current":-0.357139,"twenty":-3.228855,"median":-0.879567,"eighty":-0.48205,"marketCap":4713322},{"date":"2025-04-25","current":-0.356192,"twenty":-3.228855,"median":-0.870018,"eighty":-0.479197,"marketCap":4700830},{"date":"2025-05-02","current":-0.388573,"twenty":-3.228855,"median":-0.848849,"eighty":-0.476712,"marketCap":5128178}],"updateTime":1746277531891}}}